Cargando…
Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study
AIMS: The prognosis of nonsmall cell lung cancer with cavitation (NSCLC-c) is not well-known. We compared the positron emission tomography/computed tomography (PET/CT) findings and survival data of patients with NSCLC-c patients with those without cavitation (NSCLC-nc). METHODS: Between 7/2004 and 6...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748615/ https://www.ncbi.nlm.nih.gov/pubmed/26933457 http://dx.doi.org/10.4103/1817-1737.165296 |
_version_ | 1782415152960765952 |
---|---|
author | Nguyen, Nghi C. Abhishek, Kumar Nyon, Samuel Farghaly, Hussein Rabie S. Osman, Medhat M. Reimers, Hans-Joachim |
author_facet | Nguyen, Nghi C. Abhishek, Kumar Nyon, Samuel Farghaly, Hussein Rabie S. Osman, Medhat M. Reimers, Hans-Joachim |
author_sort | Nguyen, Nghi C. |
collection | PubMed |
description | AIMS: The prognosis of nonsmall cell lung cancer with cavitation (NSCLC-c) is not well-known. We compared the positron emission tomography/computed tomography (PET/CT) findings and survival data of patients with NSCLC-c patients with those without cavitation (NSCLC-nc). METHODS: Between 7/2004 and 6/2007, cavitary lung lesions were identified in 46/248 patients undergoing fluorodeoxyglucose (FDG) PET/CT for lung nodule characterization or lung cancer staging. Within the same period, 40 of 202 patients with NSCLC-nc were randomly selected for comparison. The primary was assessed by location, size, cell type, and standardized uptake value (SUV). Disease stage was determined according to American Joint Committee on Cancer guidelines for lung cancer. Kaplan–Meier method was used for survival analysis and Cox regression to assess the effect of clinical and imaging variables on survival. RESULTS: NSCLC-c was found in 87% of patients that had a cavitary lung lesion at PET/CT. Squamous cell carcinoma, primary size and primary-to-liver SUV ratio differed significantly between NSCLC-c and NSCLC-nc, whereas age, gender, primary location, primary SUV, type of treatment, and disease stage did not. Median survival and overall 5-year survival were 19 months and 24% for NSCLC-c, and 31 months and 31% for NSCLC-nc, P = 0.23. Disease stage was the only predictor of survival. CONCLUSION: Cavitary lung lesions in patients undergoing FDG PET/CT harbor a significant risk for cancer. NSCLC-c is associated with squamous cell carcinoma, larger size, and greater FDG metabolism compared with NSCLC-nc, although these variables may not be predictive of survival. Nonetheless, PET/CT contributes to accurate staging and has an indirect impact on prognosis. |
format | Online Article Text |
id | pubmed-4748615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-47486152016-03-01 Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study Nguyen, Nghi C. Abhishek, Kumar Nyon, Samuel Farghaly, Hussein Rabie S. Osman, Medhat M. Reimers, Hans-Joachim Ann Thorac Med Original Article AIMS: The prognosis of nonsmall cell lung cancer with cavitation (NSCLC-c) is not well-known. We compared the positron emission tomography/computed tomography (PET/CT) findings and survival data of patients with NSCLC-c patients with those without cavitation (NSCLC-nc). METHODS: Between 7/2004 and 6/2007, cavitary lung lesions were identified in 46/248 patients undergoing fluorodeoxyglucose (FDG) PET/CT for lung nodule characterization or lung cancer staging. Within the same period, 40 of 202 patients with NSCLC-nc were randomly selected for comparison. The primary was assessed by location, size, cell type, and standardized uptake value (SUV). Disease stage was determined according to American Joint Committee on Cancer guidelines for lung cancer. Kaplan–Meier method was used for survival analysis and Cox regression to assess the effect of clinical and imaging variables on survival. RESULTS: NSCLC-c was found in 87% of patients that had a cavitary lung lesion at PET/CT. Squamous cell carcinoma, primary size and primary-to-liver SUV ratio differed significantly between NSCLC-c and NSCLC-nc, whereas age, gender, primary location, primary SUV, type of treatment, and disease stage did not. Median survival and overall 5-year survival were 19 months and 24% for NSCLC-c, and 31 months and 31% for NSCLC-nc, P = 0.23. Disease stage was the only predictor of survival. CONCLUSION: Cavitary lung lesions in patients undergoing FDG PET/CT harbor a significant risk for cancer. NSCLC-c is associated with squamous cell carcinoma, larger size, and greater FDG metabolism compared with NSCLC-nc, although these variables may not be predictive of survival. Nonetheless, PET/CT contributes to accurate staging and has an indirect impact on prognosis. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4748615/ /pubmed/26933457 http://dx.doi.org/10.4103/1817-1737.165296 Text en Copyright: © 2016 Annals of Thoracic Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Nguyen, Nghi C. Abhishek, Kumar Nyon, Samuel Farghaly, Hussein Rabie S. Osman, Medhat M. Reimers, Hans-Joachim Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
title | Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
title_full | Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
title_fullStr | Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
title_full_unstemmed | Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
title_short | Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
title_sort | are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? a retrospective fluorodeoxyglucose positron emission tomography/computed tomography study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748615/ https://www.ncbi.nlm.nih.gov/pubmed/26933457 http://dx.doi.org/10.4103/1817-1737.165296 |
work_keys_str_mv | AT nguyennghic arethereradiographicmetabolicandprognosticdifferencesbetweencavitaryandnoncavitarynonsmallcelllungcarcinomaaretrospectivefluorodeoxyglucosepositronemissiontomographycomputedtomographystudy AT abhishekkumar arethereradiographicmetabolicandprognosticdifferencesbetweencavitaryandnoncavitarynonsmallcelllungcarcinomaaretrospectivefluorodeoxyglucosepositronemissiontomographycomputedtomographystudy AT nyonsamuel arethereradiographicmetabolicandprognosticdifferencesbetweencavitaryandnoncavitarynonsmallcelllungcarcinomaaretrospectivefluorodeoxyglucosepositronemissiontomographycomputedtomographystudy AT farghalyhusseinrabies arethereradiographicmetabolicandprognosticdifferencesbetweencavitaryandnoncavitarynonsmallcelllungcarcinomaaretrospectivefluorodeoxyglucosepositronemissiontomographycomputedtomographystudy AT osmanmedhatm arethereradiographicmetabolicandprognosticdifferencesbetweencavitaryandnoncavitarynonsmallcelllungcarcinomaaretrospectivefluorodeoxyglucosepositronemissiontomographycomputedtomographystudy AT reimershansjoachim arethereradiographicmetabolicandprognosticdifferencesbetweencavitaryandnoncavitarynonsmallcelllungcarcinomaaretrospectivefluorodeoxyglucosepositronemissiontomographycomputedtomographystudy |